19 June 2013
Keywords: ucb, keppra, effective, infant, seizure, study, belgian
Article | 30 April 2007
Belgian pharmaceutical group UCB says that, in a Phase III study, its oral antiepileptic Keppra (levetiracetam) reduced the frequency of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
© 2013 thepharmaletter.com